Reddit Posts
$GANX Gain Therapeutics, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Mentions
I’m guilty I hold on to speculative issues. My latest is GANX. I have several good friends with Parkinson’s. Hope GANX pans out.
Yes, there should be an update very soon. They filed the IND in December. Also, they just released a new corporate update... some good info in there: [https://gaintherapeutics.com/wp-content/uploads/2026/02/GANX-February-2026-Corporate-Deck-Final4.pdf](https://gaintherapeutics.com/wp-content/uploads/2026/02/GANX-February-2026-Corporate-Deck-Final4.pdf)
I'd say I'm committed to what the data is saying, but I know what you mean. GANX has been an extreme example of biotechs where good news is sold. But this market behavior only lasts so long. Eventually, when the ripples of the data start reaching the broader science world, I think that's where this changes. Unless it happens sooner via partnership/buyout, which I think is likely. Either way, I think we're just a few months away from this coming to a head. The world doesn't know yet. I was an investor in Mind Medicine a few years back. It was too early, but I believed (and believe) in the approach. Glad it is on an uptrend now. Totally forgot about it. Looks like daily RSI is in the overbought zone, so I might look for a pullback to take a small position again. But I'm limiting my biotech exposure. GANX has giant promise, so that's where most of my biotech allocation is. COYA is another that is at an attractive price right now, but my position there is much smaller. But I'll keep an eye on DFTX-- thanks.
Again buying some GANX for the rally of today!
All the fundamentals can be right, but if they have no cash Investors get diluted. * **As of Sept 30, 2025 (Q3 10-Q):** **31,600,000 shares** outstanding. * **As of Jan 16, 2026 (Real-Time):** **38,462,000 shares** outstanding. * **The Total Added:** **\~6,862,000 new shares. 22% dilution.** **They are burning through around 1.5million a month just operations and continuing phase 1B. I do think the bottom is around $1.4 - $1.6 because everyone is expecting some kind of partnership by march / april. I am leaning towards April personally. I have been following your posts for a while, and invested some before the runup in December and then lost much more on the drop. Idk I am probably going to add more, the data is strong, but my only concern is with the** Elevated Liver Enzymes even though they said it was transient, we don't have long term data. If you remember **Venglustat**, Sanofi’s high-profile Parkinson’s drug that famously failed in Phase 2 back in **2021** shows really promising phase 1 results. Granted these two drug work very differently, but I think BioPharma is more risk averse now and want more data. They can wait it out, they have nothing to lose, while GANX keeps diluting shareholders to keep operations going.
Can you monkeys please use your monkey powers to buy into GANX? It's for your grandpa's mental health so he can still remember your name ... Or grandma when she goes to pinch your cheeks and says "you're not my grandson's boyfriend are you????" Ganx has the cure!!! Lol
What is your guys view on GANX?
It’s really hard when the data is strong but the price goes down, which is common in biotech over shorter time periods. Some of my most successful investments have resulted from buying when the dropping price causes fear. Which is a hard time to buy, especially if one doesn’t have conviction. I’d just say hang in there. If I wasn’t already irresponsibly heavy in my GANX investment, I’d be adding here.
I continue to lose money with GANX. The science seems strong though.
I'm going with ASTS and GOOG (duh), AMPX, GANX, IREN all only if there's no major once in a lifetime event. Unfortunately, there has been a reversal today, all packaged food companies (many of which were -50% their 5 year highs as of the last few weeks) shot up, indicating people are seeking safe havens. I get the feeling this year's going to be wild.
In what way, shape, or form, has GANX been transparent with the data??! The ONLY biomarker released was GluSph. Nothing about Nfl, alpha-synuclein, lysosomal or mitchondrial markers! So this is bs to say they are transparent.. And if these biomarkers were favorable, they'd be released.
GANX participating and presenting at JPMorgan conference next week, I think that's news as before it was only known that they would be attending
At the risk of beating a dead horse, I'm still a little confused about this - I understand that average investors might not pick up on the nuances of certain scientific updates but good news is still good news. I've seen other biotech companies release positive data updates that also require deep knowledge to truly understand the details, but investors get the gist and if the takeaway is that the data is positive, the stock doesn't plummet like I've seen it happen twice now with GANX. Would love to get your pov on this!
You have to look at the recent conference poster plus today's slide to see the data you want. I added the poster piece under today's data in this info. At the end. Hope this helps. Gain Therapeutics(GANX): Maxim $7 Buy 1/6/26 : KOLs are Positive https://gaintherapeutics.wordpress.com/2026/01/06/gain-therapeuticsganx-maxim-7-buy-1-6-26-kols-are-positive/
I added back in the three patients who didn't do the exit lumbar test. Plus I sorted out the three non responders. I think they know why. I have the data at the end of this report if your interested. Gain Therapeutics(GANX): Maxim $7 Buy 1/6/26 : KOLs are Positive https://gaintherapeutics.wordpress.com/2026/01/06/gain-therapeuticsganx-maxim-7-buy-1-6-26-kols-are-positive/
Lol. Well, that makes two of us with serous money in GANX.
Gain Therapeutics(GANX): BTIG Buy 1/6/26 : KOL Event BTIG Report https://gaintherapeutics.wordpress.com/2026/01/06/gain-therapeuticsganx-btig-buy-1-6-26-kol-event/
I think GANX should not do anymore public events at all since the market reaction is always like this. No matter if it's good or bad news, to the south we go. I actually had an alarm set for yesterday to sell them all and watch from the sideline what happens, but for some reason I decided to go against my initial instinct and ended up holding. Now I'm pissed at the stupid market and most importantly to myself. I'm sure as hell going to sell before the next news event I guess it will bounce back a little bit tomorrow but will take time to get back to 3 which is my average price at the moment
30% of my portfolio is in GANX, and my portfolio is pretty big.
Think GANX, SLS and ASBP is just too important to ignore. This is going to be rocky... whatever... NFA... I bought some more. (Not banking on my entire portfolio with these buys) Also me: 
Is GANX dead...? Thought today would be better.
13/15 GANX patients had MDS-UPDRS of 4; 2 were much lower (potential outliers), that puts the 2.2 average score into a new perspective
https://www.stocktitan.net/news/GANX/gain-therapeutics-highlights-biomarker-evidence-supporting-disease-kug2co9rch67.html
Some positive news on $GANX Gain Therapeutics just came out, small group and early trial but promising nonetheless, in case anyone wants to monitor today https://finance.yahoo.com/news/gain-therapeutics-highlights-biomarker-evidence-120000261.html
IMRX and GANX have attractive entry points rn
SLS still is a gamble, there is a real case that current valuation is fair/high and people banking on something happening during JP Morgan event will probably be disappointed which could cause a (big) drop VKTX, IMRX and GANX have way more room for steep rises in the coming weeks imo
What's the deal with GANX rn, should i not be worried about a little dip before tomorrow's KOL?
What's the speculation for the GANX KOL event tomorrow?
SLS for next 6 months then GANX with SLS gains.
Sanofi is a big player in Gaucher and Enzyme Replacement Therapy. They are moving up to my most likely acquirer but Merck is also at the table. Gain Therapeutics(GANX): Final Update before Phase 1b data at January 6th KOL Event https://gaintherapeutics.wordpress.com/2025/12/31/gain-therapeuticsganx-final-update-before-phase-1b-data-at-january-6th-kol-event/
There are 50M shares fully diluted to use for any calculations. Typically with a 3 dollar stock getting 3-5x market cap is considered good. That would be in the $500m to $750m range. But here is what I think. This is a phase 2 ready asset that they have filed the clinical plan for. A big pharma could start that trial in 2 months. So the first drug that can slow down, stop and perhaps reverse Parkinsons? Even at the Phase 2 stage it has to be worth at least a billion or $20/share. Now they have 15 companies they have been working with and several that they are only sharing the latest data with so far. I dont see a company like Merck, Roche or JNJ allowing someone else to own it just because on money. Sanofi also is a big player in Gaucher and this drug(see latest data in these reports) could play well in that multibillion a year market. Gain Therapeutics(GANX): Final Update before Phase 1b data at January 6th KOL Event https://gaintherapeutics.wordpress.com/2025/12/31/gain-therapeuticsganx-final-update-before-phase-1b-data-at-january-6th-kol-event/
I like to smoke a joint and put some music on. Then I find some medial task or hobby that I can do while my mind wanders on to what the future will look like in 10 years. I try to think of what industry will be huge. Things that haven't already "popped off" like AI for example. In fact using the big winners of today can help predict what the winners of the future will be. What will be huge if AI succeeds? Personal EMP protective suit perhaps? Or maybe that little Antimony company in a geographically strategic location? And if AI fails? We'll shit maybe Ford motor company makes a comeback and we all have to take our asses back on the freeway. This is just an example of a brainstorm, have a pen and paper and write down some of these ideas.... Personal emp protective suit into googs, see if it exists or if anyone already makes something like that. Can I invest in that company? Manage risk and monitor debt/dilution/PRs By doing this I got onto rklb july/Aug 2024 around 5$ and at one point held 19 jan15'25 8$ call contracts for about 2500$ down...I sold at 7500$ and bitched out. Clearly I'm a rookie but the method is pure and my conviction in my picks grows stronger...conviction is easier to have when risk is managed. Currently buying GANX. Cheers
I've had my eyes on this for a while now. This recent news has me looking at it very positively. My only concern is possible dilution since, this shows, they have enough cash on hand for a few more months at their current pace. I would assume there would be some sort of acquisition taking place (GANX being acquired) if they aren't diluting. https://preview.redd.it/ow89o1u69lag1.png?width=770&format=png&auto=webp&s=6f28b938f5d3474716d4a7b1ceca40101bbca6a7
I would love to post about it. I just don’t think I know the science/biology well enough or feel confident enough to post as a subject matter expert. I’ve been invested in $GANX for about a year and have read as much as I can get my hands on but still shy to put myself out there. There are only so many from the general public that can speak to the biology like Correct Proposal or Micorcap. I also think it’s why the company is still flying under the radar.
I'm not disputing whatever is in this post or qhether GANX is a good investment or not, but everytime this stock gets posted its always you two (OP and the other guy commenting). Just seems suspicious
If i can offer a different perspective.. i suspect that many redditors deeply dislike the flood of AI slop posts in this sub (I’m among them and I’ve blocked tons of accounts to try to filter the noise). By formatting your post to appear like a chat-gpt output (bold headers, lots of dashes, no synthesis), it’s unclear which pieces are your convictions and which are AI. You may have done a ton of work, but it really does look like copy/paste nonsense. I believe in this company, and i bought a few hundred shares of GANX in late October (my average is about 2.5 now tho). However, endless AI slop posts constantly rattling on about a stock’s potential are becoming more prevalent; these can sometimes serve as a real red flag for prospective buyers. For the record - I don’t have any ideas of solution to fix the problem (aside from individually blocking spam-looking posts), but i sorta understand why somebody might have an averse reaction to the medium (not the message, im fully supportive of Gains work). Just one perspective from a very casual trader!
Who still holding GANX?
GANX is not in a good cash position, they are looking for a buyout partner. All eyes on Jan 6 right now
98% chance that GANX will be owned or will have partnered with a large pharma by mid 2026.
Great post. Looking forward to KOL event next week. Gain Therapeutics(GANX): Final countdown to Phase 1b data at January 6th KOL Event https://gaintherapeutics.wordpress.com/2025/12/20/gain-therapeuticsganx-final-countdown-to-phase-1b-data-at-january-6th-kol-event/
RemindMe! 345 days I take my SLS profits and shift to GANX then
is $GANX rippin' today?
Great info. We should get the data we expected in Q4 and then extended data at AD/PD. Gain Therapeutics(GANX): Final countdown to Phase 1b data at January 6th KOL Event https://gaintherapeutics.wordpress.com/2025/12/20/gain-therapeuticsganx-final-countdown-to-phase-1b-data-at-january-6th-kol-event/
Crazy man. I got stopped out last week with a very small loss on RVPH but MIST and GANX really fucked me up. I didn't lose a lot of money, but I lost my profits. Should have set a tighter stop loss which sucks too. Biotech can be a slippery slope for sure.
I’ve seen a fair amount of DD on GANX but the fact that the company is literally called Gain is the most convincing.
GANX is the only good one i have seen here
Came here to say GANX and FEMY are the two I am most strongly behind.
$GANX so much potencial. DYOR
See also PTRN, NAVN MIAX was one of the most successful IPOs this year, don't see that going away anytime soon I'm going to bet with money that ANET and SKYT do well. Haven't done it yet. GANX is my only bag on this list, asymmetric risk bet, especially with the crazy sell off last week. They'll get bought out this year, calling it now
Depends on the circumstances. Impossible to time perfectly, but momentum trading allows you to snipe on the upside. I watch a few tickers that are volatile TGB & GANX have made money for me lately. Others I keep long term and just buy on a regular schedule GLD has done well for me. I do own VOO & SCHD as stalwarts.
Depends on what you consider going to the moon. For me that probably means a triple in a year. Not bags, as I am tripled already, but GANX could triple or lose 2/3 soon. As in next 3 months. Debating whether to sell part of my position and freeroll. I also like HROW to double, and CRDOF could easily double. If you asked me which of my holdings would be most likely to double this year I would say CRDOF. I already got a triple off it this year.
Now that we now know how impressive the biomarker improvement was we can look forward to seeing more data at upcoming KOL event. Gain Therapeutics(GANX): ROTH MKM Thought on Phase 1b data: Raising price target to $10 https://gaintherapeutics.wordpress.com/2025/12/19/gain-therapeuticsganx-roth-mkm-thought-on-phase-1b-data-raising-price-target-to-10/ joeiniowa@gmail.com
GANX has insane short squeeze potential, 50% of shares traded yesterday were shorts. Already 6M over daily volume average and stock just took a 14% dip from daily high. Needs buying pressure. Could very well see $3.25 by EOD
GANX short squeeze
Insane short squeeze opportunity for $GANX
Yeah me too. I made a little off BYND but not that much. Live and learn. Yeah I felt like MIST and GANX had good news and still tanked. That's frustrating as hell. Definitely high risk high reward plays.
Thoughts on FGI, GANX, SLS today?
RIP to all you GANX holders
Extension doesn't mean they can't start PII before september, it means that patients wanted to continue the drug (80% of those enrolled in the trial - 15 out of 19). That's pretty positive, means most patients didn't have bad enough negative side effects to make them want to stop. I believe this means they're eschewing other treatment options while the trial continues (but correct me if I'm wrong) which would indicate they feel the drug is having a net positive effect. Clinical team will monitor ths group on the 1B rubric - which is primarily focused on "is this pill safe to take regularly" but may also track symptomatic data. However, even improvements are not worth much without a true double blind placebo trial. For investors, the stock is still as risky as any 1B / PII drug company would be. Lots of them fail in this process. Not a sure bet. For GANX today, I think people were expecting to see anecdotes of widespread symptomatic improvement in this trial report. Frankly, unrealistic. What we got instead was the encouraging data that the drug \*may be\* on the right track with reducing GluSph. I remain cautiously optimistic and still invested.
Gain (GANX) therapeutics already jumping back up! Probably just panic sell in combination with already high valuation of stock, make sure to buy some before it gets acquired by a large partner for the process of stage 2 trials.
Al those positive news stock drops GANX, FEMY,...
SLS and GANX both primed to rip 10-20x
Curious how you’re thinking about dilution risk here as GANX reported only about $8.8M in cash as of Sept 30 with ongoing net losses and stated they’ll need additional financing to operate beyond Q1 2026. They also have an active ATM/equity program up to $35.5M authorized, and have already raised capital under it this year. Your thoughts?
I’ve waited just under a couple of years for this data, since I bought my first $GANX share…so a couple of days, or weeks…yes I can definitely do that. All signs point to a positive read out. How positive? We’ll find out soon. I really hope for those suffering with Parkinson’s, that this will really be the first chink in its armour!
Yes, and GANX RSI was in overbought territory for 6 days in a row. It’s cooled off now (see bottom of screenshot). I think there's a good chance it dips again tomorrow, maybe down to $3.65, before it begins heading back upwards and finishes solid green. \~$3.65 is the bottom support of the trading channel it's been in been in since early November. Of course, this goes out the window if data is released in the morning. But I think the set-up is good for a Thursday release, possibly Friday. The winds will be at their backs again from a technical perspective. https://preview.redd.it/zyq3pgkzum7g1.jpeg?width=1277&format=pjpg&auto=webp&s=e8e50a613860713f55d9ae77875de56a8e2a5d3c
GANX and DRTS is my portfolio til 2026
BNAI, GANX, OTLK about to tank because I bought in
You're welcome. Also, check out TE. I just lost a bunch on short dated calls so I'm a bit salty about the company, but it was up 60% in one week before they did a share offering at the current price. This is very likely to go back up a lot, basically they are at the same price from a week ago but with a lot more cash on hand. My mistake was getting out at the top, then going right back in when it dipped a little without checking the news. This is a good entry point though, and it will pump as soon as the NASDAQ recovers. One other stock with potential catalysts this week is GANX, there's some good dd on reddit
I bought 500 shares of GANX when I first heard it at a conference sponsored by the Michael J Fox Foundation in October 2024. It was at around $2.10 and I promised myself (my mother died of Parkinsons) that I would donate my profits to the MJFF. after it became a long term gain. I think it will go up a bit more but I'm going to sell in January.
I see this market sell off as a buying opportunity for stocks you have conviction in. I have conviction in GANX.
I love that I’ve been seeing more posts about GANX recently because what they’re doing is awesome. Jumped in late November and pick up more on every dip
Always good to get another perspective from someone who analyzes biotechs professionally. One unique thing about GANX that makes it stand out form other biotechs, is there is virtually no bear case. Usually there are bears that come out to argue why such and such a drug is unlikely to work. There is none of that here. Too much pre-clinical and clinical data, plus new studies, that make this a hard drug to bet against.
SLS $2.5 Jan 16 call and GANX $5 Jan 16 call. SLS more likely to be a higher % return. NFA and there's no reason to listen to me but hey, yolo
GANX developing a drug for parkinsons disease Currently 4$ , the CEO says that even if the share is at 20$ its a buy
Gotta throw it out there- the last yolo for 2025 is GANX. Their insane results are going to get them bought out.
My top right now are VKTX SYRE for mid caps GANX is a good small cap also
Thanks for the DD as always. I can’t see a better risk/reward in the market. Really looking forward to seeing the biomarker data. It’s about time that I’m seeing more $GANX on Reddit…some stocks just don’t get picked up as much as others. For me, this is still a hidden gem, and even if it’s up 130% in the last few months, anyone buying today, its still relatively early in game. Phase 1 biotech, so yes there’s risk, but it would be a major curveball for the phase 1b data to not be a net positive for the stock.